Current Partnerships

 Licensing and Distribution Partners

Once-Daily Tramadol

• Purdue Pharma Products LP (USA)
• sanofi aventis (France)
• Paladin Labs Inc. (Canada)
• Grünenthal GmbH (France/Belgium)
• HEXAL AG (Germany)
• Merck Sharp & Dohme Limited (UK)
• Esteve SA (Spain/Portugal)
• Gruppo Angelini [Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.S.p.A.] (Italy)
• CSC Pharmaceuticals (Eastern Europe)
• iNova Pharmaceuticals (Australia) Pty Limited (Australia)
• WhanIn Pharmaceutical Co., Ltd. (South Korea)
• Lavipharm S.A. (Greece/Cyprus)
• Dr. F. Frik Ilac San ve Tic. A.S. (Turkey)
• Dexcel Pharma Technologies Ltd. (Israel)
• Nippon Shinyaku Co., Ltd. (Japan)
• Kiron Pharma (Portugal)
• Gebro (Switzerland)

OLEPTRO™

Labopharm has established a joint venture with Gruppo Angelini for the U.S. commercialization of Labopharm’s novel, once-daily formulation of trazodone, OLEPTRO™. Under the terms of the agreement, Labopharm granted the joint venture, Angelini Labopharm, the exclusive right to market and sell OLEPTRO™ in the United States. 

Research and Development Partners

• DDS-04A: Gruppo Angelini

Manufacturing Partner

• Contramid^®: Cerestar